tiprankstipranks
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Revenue

569 Followers
StatisticsMarket CapRevenue

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had a revenue of 28.09M in the quarter ending Dec 31, 2025, with -13.58%. This bring the company's revenue in the last twelve months to 84.28M, Increased -40.97%. In the fiscal year ending Dec 31, 2025, ARS Pharmaceuticals had annual revenue of 84.28M with -5.46% growth.
Revenue (ttm)
84.28M
Revenue Growth
-5.46%
P/S Ratio
9.24
Revenue/Employee
$543,729
Employees
155
Market Cap
$778.49M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
84.28M-4.87M-5.46%
Dec 31, 2024
89.15M89.12M+297,063.33%
Dec 31, 2023
30.00K-1.29M-97.72%
Dec 31, 2022
1.32M-4.19M-76.10%
Mar 31, 2022
5.51M-12.33M-69.13%
Dec 31, 2020
17.84M―+∞%
Dec 31, 2019
―――
Dec 31, 2018
―――